Muscle Pharm Corporation. Stock OTC Bulletin Board

Stocks

End-of-day quote OTC Bulletin Board
- ^USD	-

18/10/23	Second Motion for Exclusivity Period Extension Approved For MusclePharm Corporation	CI
10/10/23	FitLife Brands, Inc. completed the acquisition of Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q).	CI

18/10/23	Second Motion for Exclusivity Period Extension Approved For MusclePharm Corporation	CI
10/10/23	FitLife Brands, Inc. completed the acquisition of Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q).	CI
03/10/23	Motion for Asset Sale Approved for MusclePharm Corporation	CI
27/09/23	FitLife Brands, Inc. entered into an agreement to acquire Substantially all of the assets of MusclePharm Corporation (OTCPK:MSLP.Q) for $18.3 million.	CI
08/09/23	Stalking Horse Agreement Filed by MusclePharm Corporation	CI
01/09/23	Musclepharm Corporation Announces Resignation of Paul Karr as Director	CI
28/08/23	Second Amended Reorganization Plan and Disclosure Statement Filed by MusclePharm Corporation	CI
28/08/23	First Amended Disclosure Statement Approved for MusclePharm Corporation	CI
17/08/23	Bidding Procedure Approved for MusclePharm Corporation	CI
20/07/23	Musclepharm Corporation Terminates Gary Shirshac as Chief Financial Officer	CI
19/06/23	First Amended Reorganization Plan and DIsclosure Statement Filed by MusclePharm Corporation	CI
26/05/23	Reorganization Plan and Disclosure Statement Filed by MusclePharm Corporation	CI
12/05/23	Motion for Asset Sale Filed by MusclePharm Corporation	CI

28/06/23	SEC Charges Former MusclePharm Executives with Accounting and Disclosure Fraud	AQ
30/09/22	MUSCLEPHARM CORP : Change in Directors or Principal Officers (form 8-K)	AQ
19/09/22	MusclePharm : Accelaration/Increase of Financial Obligation - Form 8-K	PU
19/09/22	MUSCLEPHARM CORP : Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement (form 8-K)	AQ
24/08/22	MUSCLEPHARM CORP : Change in Directors or Principal Officers (form 8-K)	AQ

Manager	Title	Age	Since
Tyler Jeffrey Dillashaw PRN	Corporate Officer/Principal	-	01/10/2021
Jason Keenan PRN	Corporate Officer/Principal	-	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CHURCHILL CAPITAL CORP XI	+2.32%	-6.16%	-	-	687M
DRUGS MADE IN AMERICA ACQUISITION II CORP.	+0.15%	+0.20%	-	-	648M
BAIN CAPITAL GSS INVESTMENT CORP.	0.00%	-0.48%	-	-	601M
CANTOR EQUITY PARTNERS IV, INC.	0.00%	-0.15%	+0.98%	-	589M
CENTIEL AG	+1.83%	-1.93%	+288.54%	-73.01%	586M
AMERICAN EXCEPTIONALISM ACQUISITION CORP. A	-0.09%	-0.98%	+3.34%	-	551M
NEW AMERICA ACQUISITION I CORP.	+0.05%	-0.20%	-	-	502M
ARES ACQUISITION CORPORATION III	+0.50%	+0.30%	-	-	500M
Average	+0.59%	-2.75%	+97.62%	-73.01%	583M
Weighted average by Cap.	+0.64%	-2.89%	+99.42%	-73.01%